High Sensitivity C-Reactive Protein / Blood Draw
hs-CRP Test
A smoke alarm for low-grade inflammation. Inexpensive, informative, and not a map.
hs-CRP measures C-reactive protein at the low concentrations relevant to chronic inflammation, rather than the high levels a standard CRP detects during acute infection. Under 1 mg/L is generally considered low cardiovascular risk, 1 to 3 moderate, and above 3 higher. It tells you inflammation is present somewhere without telling you where, which makes it a branch point rather than a diagnosis.
What this test actually measures
C-reactive protein is made by your liver in response to inflammatory signalling. When something inflammatory is happening anywhere in your body, your liver produces more of it, and the amount rises within hours.
A standard CRP test is built to detect the large rises that accompany an infection or an injury. It works well for that and it is not sensitive enough for anything subtler.
The high sensitivity version measures the same protein at much lower concentrations, in the range where chronic low-grade inflammation lives. Same molecule, finer instrument, different question.
That is the distinction worth understanding. hs-CRP is not looking for the fire. It is looking for the smoke that has been drifting through the building for years without anyone noticing.
And because inflammation sits underneath cardiovascular disease, metabolic disease and a long list of chronic conditions, that quiet background level turns out to carry real information.
What the bands mean, and the honest limits
The commonly used bands come from cardiovascular risk work, largely following a 2003 paper in Circulation on the clinical application of C-reactive protein for cardiovascular disease detection and prevention. Under 1 mg/L is generally described as low risk, 1 to 3 as moderate, and above 3 as higher.
The evidence that this matters clinically is stronger than for most markers on this site. The JUPITER trial, published in the New England Journal of Medicine in 2008, randomised people with raised hs-CRP but not raised LDL cholesterol to rosuvastatin or placebo, and found a reduction in vascular events. A 2010 analysis in the American Journal of Cardiology examined how baseline hs-CRP related to those outcomes.
That is genuinely notable, because it means hs-CRP identified people who benefited from treatment who would not have been identified by cholesterol alone.
Now the limits, and they are important because this marker gets over-read constantly.
First, it tells you inflammation is present without telling you where. Joints, gut, an infection you have not noticed, visceral fat quietly generating background signalling, gum disease. It is a smoke alarm, not a map, and treating a raised hs-CRP as a diagnosis is the most common mistake made with it.
Second, a single high result frequently means very little. Any recent infection, injury, dental work or hard training session raises it temporarily. A result above 10 mg/L usually reflects something acute rather than chronic risk, and the standard advice is to repeat it a couple of weeks later when you are well rather than to act on one value.
Third, it is not sensitive enough to rule things out. A normal hs-CRP does not exclude an inflammatory condition, which is why in something like inflammatory joint disease the clinical pattern carries more weight than this number.
What it is genuinely excellent at is context for other tests. Ferritin rises with inflammation regardless of iron status, and hs-CRP is what tells you whether a comfortable ferritin can be trusted. That alone justifies adding it to an iron panel.
Test details
What is measured: C-reactive protein by high sensitivity assay, in mg/L.
Sample: blood draw.
Provider: Quest Diagnostics, ordered through Jess's practitioner dispensary.
Fasting: not required.
Turnaround: results typically within a few business days of the sample reaching the lab.
How the pricing works
I want to be straightforward about this, because lab pricing in the wellness industry frequently is not.
Jess takes no markup on the test itself. The lab cost is passed through exactly as it comes. What you pay is the test cost, the dispensary's service fee, the authorization fee, the collection fee where one applies, a flat handling fee for placing and managing the order, and the card processing cost. The handling fee is the part that is Jess's, and it is flat regardless of how expensive the test is.
That structure is deliberate. A percentage markup on labs creates an incentive to recommend expensive tests, and this way there is not one.
Because every blood test in one order shares a single draw fee, adding a second or third test to the same order costs considerably less than ordering them separately. The full lab menu shows what shares a draw with this one, and the order page itemises every fee before you pay.
Who this test is worth running for
Anyone ordering ferritin. This is the single most practical use of the test, because without it a normal ferritin is ambiguous, and both share one draw fee in the same order.
Anyone building a cardiovascular picture, alongside an advanced lipid panel. Inflammation and particle count are two separate contributors and measuring one does not cover the other.
Anyone with symptoms that could be inflammatory: persistent joint aching, unexplained fatigue, gut symptoms, or a metabolic picture with excess weight around the middle. It works as a branch point, telling you whether an inflammatory process is worth pursuing further.
Ordering restrictions
The lab network cannot issue orders to residents of New York, New Jersey, Rhode Island, or Hawaii. New York, New Jersey, and Rhode Island prohibit direct-to-consumer lab testing outright, requiring a treating provider's signature on every requisition. Hawaii is excluded by the network. This is tied to where you live, not where the sample is collected, so it applies to kits as well as draws.
If you live in one of those four states, your doctor can order the same test.
What to do with the result
If it comes back above 10 mg/L, that usually reflects something acute rather than chronic risk. Repeat it in a couple of weeks when you are well before drawing any conclusion.
If it is persistently raised across two tests, the useful question is where from. Dental health, gut symptoms, visceral fat, sleep, an undiagnosed condition. That is a conversation for a good functional medicine doctor rather than a supplement.
If it is raised alongside a comfortable ferritin, treat the ferritin with caution, since inflammation lifts it independently of your iron stores.
If it is normal but you have inflammatory symptoms, do not treat that as a clearance. This test is not sensitive enough to rule out inflammatory disease, and the clinical pattern matters more.
Read it alongside what it means. The hs-CRP page covers the bands and the JUPITER evidence in detail.
Read these alongside it
Adds it to your lab order, with every fee itemised before you pay.
What the bands mean, and what the JUPITER trial showed.
The order this test most belongs alongside.
Particle count, the other half of the cardiovascular picture.
The full menu, including everything that shares a draw with this one.
Test, do not guess
Occasional notes on which markers are worth measuring, what the current guidance actually says, and when it changes.
Questions
What is the difference between CRP and hs-CRP?›
What is a good hs-CRP level?›
Do I need to fast for an hs-CRP test?›
What causes high hs-CRP?›
Should I add this to an iron panel?›
Can I lower my hs-CRP?›
Can I order this test in any state?›
Does ordering a test here include an interpretation?›
References
- Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003. PMID 12551853
- Ridker PM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine. 2008. PMID 18997196
- Ridker PM, et al. Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the JUPITER trial. The American Journal of Cardiology. 2010. PMID 20599004
- Gulhar R, et al. Physiology, Acute Phase Reactants. StatPearls. PMID 30137854